Early Adopters | Adopting | Yet to adopt | |||||||
---|---|---|---|---|---|---|---|---|---|
A | B | C | D | E | F | G | H | J | |
BARRIERS to MDI Use | |||||||||
Evidence-based Innovation | |||||||||
   Increased cost to the ED | x | x | x | x | x | ||||
   Parental resistance | x | x | x | x | x | x | x | x | x |
   Extra time/extra work for nurses | x | x | x | x | x | x | x | ||
   Sterilization issues for the spacer devices | x | x | x | ||||||
   Cost of the spacer to the patient | x | x | x | ||||||
   (Potential) Adopters | |||||||||
   Entrenched ideas/scepticism | x | x | x | ||||||
   Not convinced by the research/no clear advantage | x | x | x | x | |||||
Practice Environment | |||||||||
   Language barrier (parents) | x | x | x | ||||||
   Concerns about overtreatment at home by parents | x | x | |||||||
   Institutional bureaucracy | x | x | |||||||
   Lack of supplies or resources | x | x | x | x | x | x | |||
   Inconsistency of use in facility/region | x | x | x | x | x | ||||
SUPPORTS/FACILITATORS to MDI Use | |||||||||
Evidence-based Innovation | |||||||||
   Clear advantage acknowledged/'buy in' | x | x | x | x | x | ||||
   Perceived reduction in transmission of infection | x | x | x | ||||||
   (Potential) Adopters | |||||||||
   Being involved in research | x | x | x | ||||||
Practice Environment | |||||||||
   Clear written protocol including MDI use | x | x | x | x | |||||
   Encouraging staff participation in the change process | x | x | x | ||||||
   Having resources for patient education | x | x | x | x | x | ||||
   Consistent treatment across department/facility/region | x | x | x | x | x | ||||
   RT support | x | x | x | x | |||||
   Presence of a research champion | x | x | x | x | |||||
   Staff presented with rationale/evidence | x | x | x | x | x | x | |||
   Adequate resources/supplies | x | x | x | x | x | ||||
   Education for staff | x | x | x | x | x | x | x |